Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 421

1.

Favourable SVR12 rates with boceprevir or telaprevir triple therapy in HIV÷ HCV coinfected patients.

Arends JE, van der Meer JT, Posthouwer D, Kortmann W, Brinkman K, van Assen S, Smit C, van der Valk M, van der Ende M, Schinkel J, Reiss P, Richter C, Hoepelman AI.

Neth J Med. 2015 Aug;73(7):324-30.

2.

Health-related quality of life in perinatally HIV-infected children in the Netherlands.

Cohen S, Ter Stege JA, Weijsenfeld AM, van der Plas A, Kuijpers TW, Reiss P, Scherpbier HJ, Haverman L, Pajkrt D.

AIDS Care. 2015 Aug 14:1-10. [Epub ahead of print]

PMID:
26272357
3.

Combination Antiretroviral Therapy for HIV in Rwandan Adults: Clinical Outcomes and Impact on Reproductive Health up to 24 Months.

Asiimwe-Kateera B, Veldhuijzen N, Balinda JP, Rusine J, Eagle S, Vyankandondera J, Mugabekazi J, Ondoa P, Boer K, Asiimwe A, Lange J, Reiss P, van de Wijgert J.

AIDS Res Treat. 2015;2015:740212. doi: 10.1155/2015/740212. Epub 2015 Jul 16.

4.

Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.

Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith CJ, d'Arminio Monforte A, Phillips A, Weber R, Lundgren J, Law MG; D:A:D Study Group.

HIV Med. 2015 Jul 28. doi: 10.1111/hiv.12294. [Epub ahead of print]

PMID:
26216031
5.

Synthesis, Internal Structure, and Formation Mechanism of Monodisperse Tin Sulfide Nanoplatelets.

de Kergommeaux A, Lopez-Haro M, Pouget S, Zuo JM, Lebrun C, Chandezon F, Aldakov D, Reiss P.

J Am Chem Soc. 2015 Aug 12;137(31):9943-52. doi: 10.1021/jacs.5b05576. Epub 2015 Aug 3.

PMID:
26200758
6.

Synthesis and surface chemistry of high quality wurtzite and kesterite Cu2ZnSnS4 nanocrystals using tin(ii) 2-ethylhexanoate as a new tin source.

Gabka G, Bujak P, Gryszel M, Ostrowski A, Malinowska K, Zukowska GZ, Agnese F, Pron A, Reiss P.

Chem Commun (Camb). 2015 Jul 30;51(65):12985-8. doi: 10.1039/c5cc04151a.

PMID:
26176023
7.

Long-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-Cohorts.

Cohen S, Innes S, Geelen SP, Wells JC, Smit C, Wolfs TF, van Eck-Smit BL, Kuijpers TW, Reiss P, Scherpbier HJ, Pajkrt D, Bunders MJ.

PLoS One. 2015 Jul 6;10(7):e0120927. doi: 10.1371/journal.pone.0120927. eCollection 2015.

8.

Clinical pharmacokinetics and pharmacodynamics of dolutegravir used as a single tablet regimen for the treatment of HIV-1 infection.

Bollen P, Reiss P, Schapiro J, Burger D.

Expert Opin Drug Saf. 2015 Sep;14(9):1457-72. doi: 10.1517/14740338.2015.1059818. Epub 2015 Jul 3.

PMID:
26134478
9.

The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection.

O'Halloran JA, Dunne E, Gurwith M, Lambert JS, Sheehan GJ, Feeney ER, Pozniak A, Reiss P, Kenny D, Mallon P.

HIV Med. 2015 Jun 25. doi: 10.1111/hiv.12270. [Epub ahead of print]

PMID:
26111187
10.

Retinal Structure and Function in Perinatally HIV-Infected and cART-Treated Children: A Matched Case-Control Study.

Demirkaya N, Cohen S, Wit FW, Abramoff MD, Schlingemann RO, Kuijpers TW, Reiss P, Pajkrt D, Verbraak FD.

Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3945-54. doi: 10.1167/iovs.15-16855.

PMID:
26087360
11.

Low mother-to-child-transmission rate of Hepatitis C virus in cART treated HIV-1 infected mothers.

Snijdewind IJ, Smit C, Schutten M, Nellen FJ, Kroon FP, Reiss P, van der Ende ME.

J Clin Virol. 2015 Jul;68:11-5. doi: 10.1016/j.jcv.2015.04.002. Epub 2015 Apr 4.

PMID:
26071328
12.

Psychometric validation of a German language version of a PROM for urethral stricture surgery and preliminary testing of supplementary ED and UI constructs.

Kluth LA, Dahlem R, Becker A, Schmid M, Soave A, Rosenbaum C, Ludwig TA, Christ N, Rink M, Reiss P, Engel O, Riechardt S, Chun FK, Fisch M, Ahyai SA.

World J Urol. 2015 Jun 7. [Epub ahead of print]

PMID:
26049865
13.

Staged urethroplasty: comparison of early functional results and quality of life in mesh graft and buccal mucosa technique.

Pfalzgraf D, Kluth L, Reiss P, Fisch M, Dahlem R.

Can J Urol. 2015 Apr;22(2):7720-6.

PMID:
25891336
14.

An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.

Friis-Møller N, Ryom L, Smith C, Weber R, Reiss P, Dabis F, De Wit S, Monforte AD, Kirk O, Fontas E, Sabin C, Phillips A, Lundgren J, Law M; D:A:D study group.

Eur J Prev Cardiol. 2015 Apr 16. pii: 2047487315579291. [Epub ahead of print]

PMID:
25882821
15.

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group.

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.

16.

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.

Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C; D:A:D study group.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):568-77. doi: 10.1097/QAI.0000000000000523.

PMID:
25763785
17.

Research in action: from AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep Lange.

Boender TS, Barré-Sinoussi F, Cooper D, Goosby E, Hankins C, Heidenrijk M, de Jong M, Kazatchkine M, Laoye F, Merson M, Reiss P, Rinke de Wit TF, Rogo K, Schellekens O, Schultsz C, Sigaloff KC, Simon J, Zewdie D.

Antivir Ther. 2015;20(1):101-8. doi: 10.3851/IMP2946. Epub 2015 Feb 18. No abstract available.

PMID:
25691450
18.

Prospects of nanoscience with nanocrystals.

Kovalenko MV, Manna L, Cabot A, Hens Z, Talapin DV, Kagan CR, Klimov VI, Rogach AL, Reiss P, Milliron DJ, Guyot-Sionnnest P, Konstantatos G, Parak WJ, Hyeon T, Korgel BA, Murray CB, Heiss W.

ACS Nano. 2015 Feb 24;9(2):1012-57. doi: 10.1021/nn506223h. Epub 2015 Jan 22.

PMID:
25608730
19.

Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.

Zhang S, van Sighem A, Kesselring A, Gras L, Prins JM, Hassink E, Kauffmann R, Richter C, de Wolf F, Reiss P; ATHENA national observational HIV cohort study.

HIV Med. 2015 May;16(5):265-72. doi: 10.1111/hiv.12202. Epub 2015 Jan 21.

PMID:
25604160
20.

Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era.

Schoffelen AF, Smit C, van Lelyveld SF, Vogt L, Bauer MP, Reiss P, Hoepelman AI, Barth RE; ATHENA National Observational HIV Cohort.

J Infect Dis. 2015 Jul 15;212(2):264-74. doi: 10.1093/infdis/jiv026. Epub 2015 Jan 18.

PMID:
25601941
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk